Aignosis - Total Funding, Funding Over Time, Funding By Rounds and More
Founded in 2024, Aignosis operates in the AI sector offering AI-based solutions for the early screening of Autism. The company's focus is on improving the accuracy and accessibility of Autism diagnosi...
Funding stage:
Seed
Last funding:
30/09/2026
Total funding:
$416.00K+
Revenue:
Investors
Employee count:
20
Last 90d
20
Last 90d
Web traffic:
3.29K
3.29K
Last 30d
Last 30d
Aignosis: Funding Highlights
Funding highlights of Aignosis and a snapshot of its key metrics.
Total Funding$416.00K+
Current StageLate Stage
Total Round(s)1
Funding Rounds
FAQs on Funding of Aignosis
An AI Funded Aignosis has raised a total funding of $416.00K as of 01 October 2026 across 1 rounds. Find the details around funding rounds, participating investors, and other insights of Aignosis here...
Aignosis has raised a total of $416.00K across 1 funding rounds and the last round was raised on 01 October 2026.
Aignosis's key investors include Antler, IIMA Ventures, Nikhil Kamath and 1 other.
Aignosis's latest funding round was $416.00K in Late Stage, raised on 01 October 2026.
Aignosis is at the Late stage. Its most recent round was raised on 01 October 2026.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links